Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-01-31

Clinical Trial Update: Chemotherapy Plus Vaccination to Treat Mantle Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating chemotherapy plus vaccination for mantle cell lymphoma has completed; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Mantle Cell Lymphoma, Lymphoma, Mantle Cell | Phase 2 | Status: COMPLETED | Results posted: 2023-01-31